These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15743665)

  • 1. DeltaNp53 or p44: priming the p53 pump.
    Scrable H; Sasaki T; Maier B
    Int J Biochem Cell Biol; 2005 May; 37(5):913-9. PubMed ID: 15743665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
    Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
    BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.
    Li M; Pehar M; Liu Y; Bhattacharyya A; Zhang SC; O'Riordan KJ; Burger C; D'Adamio L; Puglielli L
    Neurobiol Aging; 2015 Oct; 36(10):2725-36. PubMed ID: 26174856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
    Lin SC; Karoly ED; Taatjes DJ
    Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
    Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
    J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mammalian life span by the short isoform of p53.
    Maier B; Gluba W; Bernier B; Turner T; Mohammad K; Guise T; Sutherland A; Thorner M; Scrable H
    Genes Dev; 2004 Feb; 18(3):306-19. PubMed ID: 14871929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death.
    Pehar M; O'Riordan KJ; Burns-Cusato M; Andrzejewski ME; del Alcazar CG; Burger C; Scrable H; Puglielli L
    Aging Cell; 2010 Apr; 9(2):174-90. PubMed ID: 20409077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the newer p53 family proteins in malignancy.
    Irwin MS; Kaelin WG
    Apoptosis; 2001; 6(1-2):17-29. PubMed ID: 11321038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.
    Courtois S; Verhaegh G; North S; Luciani MG; Lassus P; Hibner U; Oren M; Hainaut P
    Oncogene; 2002 Oct; 21(44):6722-8. PubMed ID: 12360399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
    Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
    Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 isoforms can regulate p53 transcriptional activity.
    Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
    Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
    Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
    Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
    Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
    Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human p53 activity and cell localization by alternative splicing.
    Ghosh A; Stewart D; Matlashewski G
    Mol Cell Biol; 2004 Sep; 24(18):7987-97. PubMed ID: 15340061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRES mediated translational regulation of p53 isoforms.
    Sharathchandra A; Katoch A; Das S
    Wiley Interdiscip Rev RNA; 2014; 5(1):131-9. PubMed ID: 24343861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
    Courtois S; Caron de Fromentel C; Hainaut P
    Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and expression of p63 isoforms in human keloids.
    De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
    Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
    Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
    Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.